PRESS RELEASE published on 11/25/2025 at 07:00, 4 months 7 days ago Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination Relief Therapeutics and NeuroX reveal joint presentation and financial outlook in anticipation of business combination. Financial guidance includes revenue projections and EBITDA margin targets Business Combination Financial Outlook Relief Therapeutics Press Conference NeuroX
BRIEF published on 11/14/2025 at 18:25, 4 months 17 days ago Relief Therapeutics Shareholders Approve Merger with NeuroX Leadership Changes Shareholder Approval Capital Increase Relief Therapeutics NeuroX Merger
BRIEF published on 11/14/2025 at 18:25, 4 months 17 days ago Les actionnaires de Relief Therapeutics approuvent la fusion avec NeuroX Augmentation De Capital Approbation Des Actionnaires Thérapeutiques De Soulagement Fusion De NeuroX Changements De Leadership
PRESS RELEASE published on 11/14/2025 at 18:20, 4 months 17 days ago Relief Therapeutics Shareholders Approve Business Combination with NeuroX Relief Therapeutics shareholders approve business combination with NeuroX, creating a digital neurotherapeutics company. New board members elected. Business combination expected to close in December 2025 Shareholders Business Combination Relief Therapeutics NeuroX Digital Neurotherapeutics
BRIEF published on 10/29/2025 at 07:05, 5 months 4 days ago Relief Therapeutics annonce des résultats positifs dans l'étude RLF-OD032 Approbation De La FDA RLF-OD032 Traitement De La Phénylcétonurie Étude De Bioéquivalence Dichlorhydrate De Saproptérine
BRIEF published on 10/29/2025 at 07:05, 5 months 4 days ago Relief Therapeutics Reports Positive Outcomes in RLF-OD032 Study FDA Approval RLF-OD032 Phenylketonuria Treatment Bioequivalence Study Sapropterin Dihydrochloride
PRESS RELEASE published on 10/29/2025 at 07:00, 5 months 4 days ago Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 Relief Therapeutics announces positive results from pivotal bioequivalence study of RLF-OD032, demonstrating bioequivalence to KUVAN®, supporting NDA submission in early 2026 FDA Approval Relief Therapeutics RLF-OD032 Bioequivalence Study PKU Treatment
BRIEF published on 10/24/2025 at 07:04, 5 months 9 days ago Relief Therapeutics convoque une assemblée générale extraordinaire pour une fusion d'entreprises Assemblée Générale Extraordinaire THÉRAPEUTIQUE DE SECOURS Regroupement D'entreprises MindMaze Therapeutics Groupe NeuroX
BRIEF published on 10/24/2025 at 07:04, 5 months 9 days ago Relief Therapeutics Schedules Extraordinary General Meeting for Business Merger Business Combination Extraordinary General Meeting Relief Therapeutics MindMaze Therapeutics NeuroX Group
PRESS RELEASE published on 10/24/2025 at 06:59, 5 months 9 days ago Relief Therapeutics Convenes Extraordinary General Meeting Relief Therapeutics announces Extraordinary General Meeting to seek shareholder approval for business combination with NeuroX Group SA EGM Business Combination Extraordinary General Meeting Relief Therapeutics NeuroX Group SA
Published on 04/02/2026 at 07:30, 38 minutes ago Caldwell Expands Consumer Practice with Addition of Domenic Falzarano in Dubai
Published on 04/02/2026 at 04:00, 4 hours 8 minutes ago MedMira Reports Second Quarter Results FY2025
Published on 04/02/2026 at 00:55, 7 hours 13 minutes ago Silver Spruce Resources Inc. Announces Close of $739,250 First Tranche of Non-Brokered Private Placement and Extension
Published on 04/02/2026 at 00:00, 8 hours 8 minutes ago Redwood AI Launches Collaborative Research Project with UBC's Brent Page Lab Focused on Alzheimer's Drug Discovery
Published on 04/02/2026 at 07:45, 23 minutes ago Sensirion partners with ClimeFi for durable carbon removal
Published on 04/02/2026 at 07:30, 38 minutes ago Nordex Group expands wind farm in Germany by an additional 40 MW
Published on 04/02/2026 at 07:00, 1 hour 7 minutes ago Swiss Life Asset Management AG: Swiss Life REF (CH) ESG Diversified Commercial Switzerland: successful listing on SIX Swiss Exchange
Published on 04/02/2026 at 07:00, 1 hour 7 minutes ago Swiss Life Asset Management AG: Swiss Life REF (CH) ESG Diversified Commercial Switzerland: cotation réussie à la SIX Swiss Exchange
Published on 04/02/2026 at 07:00, 1 hour 7 minutes ago Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) : données clés pour la cinquième augmentation de capital
Published on 04/02/2026 at 08:05, 3 minutes ago Neoen announces the launch of France's largest battery
Published on 04/02/2026 at 08:05, 3 minutes ago Neoen annonce le lancement de la plus grande batterie de France
Published on 04/02/2026 at 08:00, 8 minutes ago Availability of the preparatory documents for the Annual General Meeting of OPmobility SE
Published on 04/02/2026 at 08:00, 8 minutes ago Mise à disposition des documents préparatoires à l’Assemblée Générale Annuelle d’OPmobility SE
Published on 04/02/2026 at 08:00, 8 minutes ago Neoen announces Ako Battery, its first big battery in Japan, during the French President’s official visit
